Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-24 @ 10:42 PM
NCT ID:
NCT06272435
Eligibility Criteria:
Inclusion Criteria:
* body mass index (BMI) \<35 kilgrams per square meter
* consistent dietary intake and exercise throughout study period
* consumes 2 liters (women) or 2.5 liters (men) of water per day prior to study visits
* able to fast for 15 hours
Exclusion Criteria:
* sensitivity or be allergic to any components of the study product they will be excluded.
* tobacco user
* specialized diet (low carbohydrate/ketogenic diet, carnivore diet, intermittent fasting, etc.)
* caffeine consumption within 12 hours of study visit
* strenuous activity within 24 hours of study visit
* history or presence of a clinically relevant (that required or requires treatment) cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder
* conditions that alter fluid balance or electrolytes/hydration status
* consuming any medication which may alter fluid retention/electrolyte levels such as sodium-glucose co-transporter 2 (SGLT2) inhibitor (for type 2 diabetes), laxatives, diuretics, Apremilast, chemotherapy, or lithium.
* consuming nutritional supplements, performance enhancing drugs, and/or non-steroidal anti-inflammatory drugs within 7 days of study visits excluding screening).
* employee of Liquid IV
* be enrolled in another clinical study within 30 days of the first study visit
* active infection or illness of any kind
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT06272435
Study Brief:
Protocol Section:
NCT06272435